>>521
Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus
Report of the AAN Guidelines Subcommittee
https://www.neurology.org/doi/full/10.1212/WNL.0000000000213604